Samsung Biologics to build first overseas factory in US

SourceThe Korea Herald
Date Published06/14/2022
Author NameKan Hyeong-woo
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Samsung Biologics
Parent companySamsung Group
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Country(ies) from which reshored:Korea, Democratic People's Republic of
If relevant, work nearshored to:-
Product(s) reshoredbiopharmaceutical Contract Development
What domestic positive factors made reshoring more attractive?Higher productivity, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market
Find Reshoring Articles